# AllerPops

Liberate Millions from Allergies

## Elevator pitch
We manufacture and distribute AllerPops, an all-natural allergy remedy that relieves airborne allergies for months to years.

- Canonical URL: https://wefunder.com/allerpops
- Entity ID: wefunder:company:73355
- Last updated: 2026-06-15T05:00:31Z
- Generated at: 2026-06-15T21:33:37Z

## Quick facts
- 🧪 Clinical trials confirm in Oct. 2022 AllerPops can cure allergies with lasting relief!
- 😀 94.5% efficacy rate for allergy relief, based on a survey of about 100 of our 10,0000+ customers!
- 🦸 CEO Dr. Cliff Han, biologist 28 years, 300+ peer-reviewed papers & has human genome project exp.
- 🧬 DNA data verify in 2017 & 2023 AllerPops promote oral probiotics & remove the cause of allergies.
- 🗄 Seven patents issued (US & international), protecting both composition & method.
- 💰 More than $230K in revenue was generated during product development and market testing.
- 🍭 100 USA million allergy sufferers could use AllerPops to see up to years of allergy relief.
- ☂️ The rest of the USA population of 230 million can use AllerPops to prevent allergies.

## Active fundraises
- wefunder:fundraise:75568: 4(a)(6) successful (USD)
- wefunder:fundraise:75569: 4(a)(6) successful (USD)
- wefunder:fundraise:39692: 4(a)(6) successful (USD)

## Story
We have discovered that the cause of allergies (allergic rhinitis) is the lack of good bacteria in the mouth or oral probiotic deficiency. AllerPops provide safe and natural support for the good bacteria (probiotics) in the mouth.  The pops balance the immune system with expertly formulated, FDA-approved ingredients and cure allergies by correcting the root cause of allergic rhinitis.We have paved the foundation in the last ten years for AllerPops to grow and thrive.Letter from our CEODear Future AllerPops Investor,Thank you for your interest in Allerpops, the first cure for allergy sufferers worldwide.We’ve created a breakthrough product that actually relieves allergy suffering for months and up to 2 years! Our over-the-counter Allergy Pop provides the easiest and longest relief, unlike anything on the market.I’m proud to announce that Allerpops recently completed clinical and DNA sequencing analyses confirming AllerPops' function and working mechanism.And we’re finally ready to open the market.I regard myself as very fortunate to have discovered the cause of allergies and invented AllerPops as the ultimate solution.I did not originally set out to change the world of allergies; the solution found me.It started on an uncharted path almost ten years ago.My book "Nothing to Sneeze At" describes my encounters in charting the road. I enjoyed the many ups and cried at many of the downs along the way.I wouldn’t change anything about the journey.The invention of AllerPops is the missing twin of the discovery of penicillin which kills bad bacteria and saves the lives of millions. AllerPops grow good bacteria and increase the quality of life for billions.Check out our plan, and I hope you will join us on the way!Sincerely,Cliff Shunsheng HanThe ProblemCurrent solutions are filled with chemicals and must be taken daily. They act as a temporary fix, only masking the symptoms and completely ignoring the root cause.Without updated allergy relief treatments, people continue to suffer from worsening symptoms and are at risk of autoimmune disorders.Our SolutionAllergies worsen if you do not have enough beneficial probiotic bacteria in your mouth. These probiotics pacify the immune system, preventing pointless attacks on harmless substances and the manifestation of symptoms.AllerPops and associated methods have been protected by six US patents, (US Pat No.: 11,364,217, No.: 11,083,759, No.: 11,083,760, No.: 10,398,670, No._9,795,579, US 10,471,033 B2). In addition, we have submitted patent applications to 5 major international markets. This year, AllerPops invested funds from their last raise to validate their efficacy through double-blind, placebo-controlled clinical trials performed by an independent clinical trial company. The results demonstrated that: AllerPops is effective for lasting allergy relief and safe to use.Check out what our customers shared about their symptom relief.What People Are SayingPressMarket OpportunityAllerPops is in a league of its own.TractionSince our last Wefunder raise, the independent phase II clinical trial confirmed AllerPops is effective, safe, and corrects the root cause of allergies.  This will allow for FDA approval and labeling.AllerPops has expanded our wholesale distribution with regional independent pharmacy partnerships and continues to increase online sales through the AllerPops site and Amazon. Business PlanAllerPops' Go-To-Market StrategyMarketing StrategyAllerPops’ overarching market strategy is thought-leader-based (EXPERTISE) marketing to build AllerPops as the leader in allergy treatment and prevention. In doing so, they will keep a lean internal organizational structure and align with third-party services to fulfill our marketing needs in the next two years.Dr. Han often compares marketing to burning a furnace. The product and service are the structure of the furnace. The content, story, and useful information are the fuel. Frequent posts on social media are the base flameInfluencer marketing the mid-flamePR-facilitated earned media exposure to the top flame with the highest temperature.To further strengthen and enrich AllerPops’ content, we will report our clinical trial in a peer-reviewed journal. In addition, they will publish a book about Dr. Han’s journey of innovating AllerPops in early 2023. The title of the book is “Nothing to Sneeze at.”Allerpops will select and engage high-performance experts in SEO, content marketing, PPC, social media, influencer marketing, and public relation to market their expertise, product, and service. AllerPops' efforts will geographically tilt to the top 50 US allergy capitals that tend to be in the south, southeast, and east regions and temporally follow the allergy season progress from south to north in the spring and reverse pattern in the fall. AllerPops will transition from a DTC to a wholesale business model, increasing the scalability and reach to allergy sufferers worldwide.The shifting to a wholesale model in the next several years is expected to exponentially increase revenue over a much shorter period. In addition, AllerPops will continue to cultivate relationships with trusted pharmacies and retailers.Forward-looking projections are not guaranteed.VisionAllerPops will be using the raised funds to launch their new branding and marketing campaign (50%), scale up inventory production (25%), and complete their FDA application (5%) and others (20%).7.5% of funds raised will go towards the Wefunder intermediary fee.Together with our investors, we will liberate millions from the US and billions worldwide who suffer from allergies. After all, with your ultimate support, nothing can stop us from reaching our goals.We are the Peacemakers between allergy sufferers and mother nature!Come and join us today to pop the allergies.Reach Out: info@allerpops.com; phone: 505 695 4236.

## FAQ
1. **Hello. What was your 2020 income total? What are your revenue goals for the next 5 years? Also, is it effective against itching?**
   - Hello Leonardo, Thanks for your interest in AllerPops. Here are our answers to your questions. The revenue in 2020 is $41,501, almost 30% lower compared to 2019. The reasons include 1. we dropped the unit price by 38% in the fourth quarter of 2019 according to a marketing survey. 2. Sales dropped almost 50% after the nation was shut down in March 2020. Even with that, we sold about 10% more units in 2020 than that in 2019. Altogether, we regard the period between 2018 -2020 as the startup sta...
2. **Hello, I just spoke to my physician today that I had to stop taking my allergy meds because the antihistamines in it were giving me side effects. I both invested a small amount and purchased a box of your pops on Amazon. I read all the online reviews and my understanding until...**
   - Hello, Vilem, I appreciate your interest in AllerPops and give us the opportunity to address your concerns. Here are our answers to your three questions. 1. Taste: We have planned to improve AllerPops from taste, shape, color, and packaging. The next version of AllerPops is in golden color, clear, and jujube flavored. We had several dozens of people who tasted it and compared it to the original one. Most (2/3) people like the new version better. The new version also replaced several ingredien...
3. **Dear Cliff, I'm new to this subject, but I'm intrigued and would like to know more. What is the cost to a consumer: (1) How much for a pop; (2) How many pops needed to remedy the allergy; and (3) How long does a consumer need to take the pops?**
   - Hi Naser, I appreciate your questions. The cost for a box of 12 pops is $24.95. On average, a person needs 6 pops within 11 days to get a satisfying result that lasts for months to years. Take additional pops only when symptoms come back. Oral hygiene and other personal events are related to how long the result can last. Please read our blogs and FAQs at allerpops.com for more details. Thanks, Cliff Han AllerPops Corp
4. **What is your current burn rate and when do you foresee the financial break-even point?**
   - Hi Justin, Our current burn rate is $14,285/month. I foresee we will quickly pass the break-even point and profit with multiple million-dollar sales within 12-16 months after the clinical trial. Thanks, Cliff
5. **Hello, I tried searching for your Primary Research paper in a peer-reviewed journal but I am not able to find such a reference. I think if you were to conduct an independent peer-review it would lend much more credibility to your claims and convince more investors/customers.**
   - Joseph, I agree. that is why we are doing the clinical trial and plan to publish the results in a peer-reviewed journal. Thank you, Cliff Han AllerPops Corp

## Team
- Cliff Han (Founder and CEO)
- Paul J. Scott (CMO)
- Amanda Giannini (CFO)
- Stuart Rose (Advisor)

## Recent posts
- AllerKream (2023-12-14T03:06:36Z)
- Last call for AllerPops and a huge thank you! (2023-07-31T23:53:28Z)
- Last day to Invest - Round Closing! (2023-07-31T15:27:48Z)
- Final two days (2023-07-30T20:00:26Z)
- 4 Days Remaining (2023-07-27T14:57:47Z)
- AllerPops Round Closing - Only a few days remain (2023-07-25T14:22:11Z)
- Allerpops Round Closing (2023-07-18T16:10:04Z)
- Last Chance to Invest in Allerpops! (2023-07-12T16:53:44Z)
- Attention - Publication of AllerPops Clinical Trial (2023-06-28T18:06:49Z)
- You are Invited: The Beginning of the End of the Allergy Era - Live in Albuquerque (2023-06-22T16:03:54Z)
- New AllerPops Webinar - An Interview with Dr. Cliff Han (2023-06-15T17:07:13Z)
- Announcing our First Japan Patent Approval (2023-06-07T00:07:12Z)
- 7 Things I’ve Learned as an Entrepreneur (2023-06-02T15:18:47Z)
- Interview - Key AllerPops investor believes this may be a 'Thomas Edison moment' (2023-05-23T12:10:35Z)
- AllerPops Event Success - Book Signing and Ribbon Cutting (2023-05-16T22:21:00Z)

## Q&A
- Q: Are you planning another investment round in the future? I will invest if it works for me, but I won't see the results before your closing date.
  - A: Dear Ignacio, It is possible to have another round of crowdfunding. But our next move is to reach out to other sources of funding. It will all depend on how all those efforts will pan out. The best way for you to make a decision is based on current evidence on if the product works and if the team can accomplish the mission. Thank you, Cliff Han AllerPops Corp
- Q: Hello, I just spoke to my physician today that I had to stop taking my allergy meds because the antihistamines in it were giving me side effects. I both invested a small amount and purchased a box of your pops on Amazon. I read all the online reviews and my understanding until I try it myself is that the purchasers had three main areas of concern with your product: 1) not the best taste 2) not so easy to follow instructions - I went to your website and I think the instructions that you had there were straight forward 3) it did not work on some of them Please could you provide your feedback on the two areas of concern 1 and 3? Do you plan to address any of these three concerns, or this is it and the customers can either take it or leave it as is?
  - A: Hello, Vilem, I appreciate your interest in AllerPops and give us the opportunity to address your concerns. Here are our answers to your three questions. 1. Taste: We have planned to improve AllerPops from taste, shape, color, and packaging. The next version of AllerPops is in golden color, clear, and jujube flavored. We had several dozens of people who tasted it and compared it to the original one. Most (2/3) people like the new version better. The new version also replaced several ingredients that some people are sensitive to. We will make AllerPops with other flavors when the sale volume can support that. 2. Method: We have been improving the method to use AllerPops since the beginning and there is no extra prep needed currently. You can simply take it after your oral hygiene routine. 3. Why AllerPops does not work in some cases? The most common reason for AllerPops not working is oral hygiene. Excessive oral hygiene with antibacterial chemicals may prevent AllerPops from working properly. We now (2023) have solved the issue with AllerPops prebiotic toothpaste. Our toothpaste does not have antibacterial chemicals to kill the good bacteria and can help them to recover with added prebiotics. We started to sell the toothpaste in April 2023 and introduced the starter kit that consists of AllerPops and the toothpaste. Fewer people did not follow the instruction and expected AllerPops works the same way as antihistamine drugs. They sucked a pop and did not feel any change. They reported that it does not work. The other rare reasons may include a) their specific microbial community does not respond to the promotion of AllerPops, b) their allergies were not caused by oral probiotic deficiency. We will continue to improve our products and services. Thank you, Cliff Han AllerPops Corp
- Q: I live in Phoenix Az. For 30+ years my allergy has been very bad. So far tried almost every allergy medicine. Been treated by the most reputable allergy doctor. Was seeing him once a week to take allergy shots. Nothing helped me. March is the month everything is blooming in Arizona. Citrus trees, olive trees, and other desert vegetation made my sinus very uncomfortable. This time of the year my pockets were full of tissues. When I saw the AlertPops raising money I was skeptical. Last month in February I bought on Amazon a box with 12 AlerPops to try out. I followed the instruction and finished the 12 Pops. After a few days I notice relief. Last few days I worked in my small garden and spent time outside without having allergy symptoms. Right now, everything is blooming in Phoenix and for the first time in many years, I do not have any allergy symptoms. I believe the AlerPops I took helped me and I'm very excited about this product.
  - A: Dear Grigore, I am so happy you can enjoy the spring now. Appreciate very much your sharing your experience with us. It'll be a great help if you can post it as a review on Amazon and tell it on your social media accounts. Thank you very much.
- Q: EVENING DR HAN HOW HAVE YOU BEEN I AM A NEW INVESTOR ? WITH HEALTH CANADA AND FDA APPROVAL WHAT MARKETING & PROMOTIONAL STRATEGY WILL WE NEED TO USE TO PROMOTE OUR PRODUCT TO THE WORLD AND WHATS THE FIRST YEAR PROJECTED GOAL WE SHOULD HOPE TO REACH
  - A: Hi James, I appreciate your support. We will have an exciting journey ahead. Associated with AllerPops is our movement for better health by taking care of good bacteria associated with us, not only in the gut but also in our mouth, airway, and on our skin. The publication of our clinical trial and theory behind AllerPops will put us at the forefront of this movement. Therefore, we will use that position to promote our product with a thought leader marketing approach. Some details are described in the story of the campaign at the section "pathway to multiple million-dollar sales." Within 12 months after this Wefunder campaign, we will finish the clinical trial and start the media promotion. These efforts should jumpstart the national sales in 2022 to two million dollars. Thank you, Cliff Han AllerPops Corp
- Q: Hello. What was your 2020 income total? What are your revenue goals for the next 5 years? Also, is it effective against itching?
  - A: Hello Leonardo, Thanks for your interest in AllerPops. Here are our answers to your questions. The revenue in 2020 is $41,501, almost 30% lower compared to 2019. The reasons include 1. we dropped the unit price by 38% in the fourth quarter of 2019 according to a marketing survey. 2. Sales dropped almost 50% after the nation was shut down in March 2020. Even with that, we sold about 10% more units in 2020 than that in 2019. Altogether, we regard the period between 2018 -2020 as the startup stage with product development and marketing test. We expect to reach multiple million-dollar sales shortly after the clinical trial (12-16 months from now). Our goal is to reach over 100 million-dollar sales within 5 years. AllerPops is effective against itching eyes, nose, and throat. Its effectiveness against itching skins other than the head and neck area varies. Thank you, Cliff Han AllerPops Corp
- Q: Can you please share your updated financials (Approximate Revenue / Loss / Runway) for end of 2022? I am very interested in what you are doing and the impact you can make globally but would like to see the updated information if possible before investing. Thank you!
  - A: Hi Jason, Here is the 2022 profit and loss statement directly from Quickbook that has not been reviewed by our CPA and may be modified later, https://drive.google.com/file/d/1EKh-rLCAfhTRz0tfqTJ2n4AoDBEeIWg6/view?usp=share_link. Our current runway is about three months. Thanks to Wefunder's rolling disbursement practice, we should be able to extend the runway as the campaign progress. Please feel free to book a meeting with me if you want a deeper understanding of our plan, https://calendly.com/cliffhan/15min? Sincerely, Cliff Han, CEO, and Founder AllerPops Corp
- Q: Hello Dr Han, as you are the sole director, officer and hold 93% of voting rights. a. Can you please share the planned corporate structure for the next 12-24 months. b. the outstanding debts raise some concerns with a short term load of 25% interest and multiple other longer term loans that appear to be in a personal name Cliff Han rather than the business name. Does the Allerpops business hold the liability for those loans? c. What is the relationship of Allerpops to Knoze Jr?
  - A: Hi Lara, Thank you for asking those questions. a. AllerPops is a C corp. We plan to build up the board of directors as we absorb external investment. The company is raising this round on wefunder.com and off the platform through angels and VCs. We are in contact with some angels and VCs. We plan to invite the lead investor to our board of directors when we close significant deals and elect an independent director. We also will invite more people to be our advisors and form our advisory board. Internally, we are looking for someone who has led to expanding consumer product sales to multiple millions of dollars as a CMO or other senior position. We likely will need a COO next year. b. We have less than $60K short-term debt and will close that after this round of raise. We regard long-term debt with low-interest rates as a benefit for our current and future investors in the long run. c. Knoze Jr is the former name of the company, and we will use AllerPops going forward. The Internet usually has a long memory. Sincerely, Cliff Han, CEO, and Founder AllerPops Corp
- Q: Hello, I tried searching for your Primary Research paper in a peer-reviewed journal but I am not able to find such a reference. I think if you were to conduct an independent peer-review it would lend much more credibility to your claims and convince more investors/customers.
  - A: Joseph, I agree. that is why we are doing the clinical trial and plan to publish the results in a peer-reviewed journal. Thank you, Cliff Han AllerPops Corp
- Q: What is your current burn rate and when do you foresee the financial break-even point?
  - A: Hi Justin, Our current burn rate is $14,285/month. I foresee we will quickly pass the break-even point and profit with multiple million-dollar sales within 12-16 months after the clinical trial. Thanks, Cliff
- Q: Dear Cliff, I'm new to this subject, but I'm intrigued and would like to know more. What is the cost to a consumer: (1) How much for a pop; (2) How many pops needed to remedy the allergy; and (3) How long does a consumer need to take the pops?
  - A: Hi Naser, I appreciate your questions. The cost for a box of 12 pops is $24.95. On average, a person needs 6 pops within 11 days to get a satisfying result that lasts for months to years. Take additional pops only when symptoms come back. Oral hygiene and other personal events are related to how long the result can last. Please read our blogs and FAQs at allerpops.com for more details. Thanks, Cliff Han AllerPops Corp
- Q: Please advise, do you have a paper (or a number of them) on this topic in peer-reviewed journals with high impact factor?
  - A: This is one of the goals of the current clinical trial.
- Q: You have $7.5M Series A valuation, you show some of your metrics, still to decide on the investment other key metrics are essential (https://www.ycombinator.com/library/1y-key-metrics): • Total visits • Total unique visitors • Total customers • Conversion rate • Total registered accounts • Revenue • Revenue CMGR • Gross margin • Customer retention • Order frequency • Average order value • Customer LTV / paid CAC • Net working capital as % of change sales • Burn rate / runway Could you please share them so we could see the trends of your company, the consistency and the past data. If you have inconsistent data (pitfall #2, https://www.ycombinator.com/library/1z-the-importance-of-trends) as many startups do, please elaborate on the reasons. Could you please advise how did you come up to $7.5M valuation cap as well.
  - A: Aldert, Please go through each tab of the campaign page, and you will find most of your answers there. Sorry for not repeating them here. Best regards, Cliff Han AllerPops Corp
- Q: Hi Cliff, Congratulations on the Clinical Trial Results. Question: Your advertising & marketing expenditure in 2021 was 2.8x your revenue. How can this be explained, given one of your major distribution channels is Amazon itself? What are the current and forecasted customer acquisition costs for DTC and Wholesale distribution channels? Kind regards, Pablo
  - A: Hi Pablo, Please be aware that our focus in the last several years has been researching and development and we have not systematically marketed our product yet. Therefore, the previous marketing spending is not effective. We are starting our thought leader-based marketing campaign and expect to improve the CAC to around $15 by end of this year. Thanks, Cliff Han
- Q: How does this work? I invested $500.00. How do I see what the value of that investment is, and what if I want to withdraw the investment? Not sure how any of it works. Thank You Kathleen Mack
  - A: Hi, Kathleen, Please visit the Wefunder FAQ page about the basics related to your investment on the platform. https://help.wefunder.com/#/investor/getting-started-for-investors Thanks, Cliff
- Q: Hello ! where can we see the clinical trial , I do not understand about "FDA" approval ? are you marketing as a nutraceutical or a Drug. Where can we see the patents ? Regards Dr.C
  - A: Hi Richard, Here is the preprint of the manuscript reporting the results of the clinical trial: https://www.medrxiv.org/content/10.1101/2023.07.20.23291433v1. We are going to get FDA approval to label AllerPops with a claim, such as "anti-inflammation" or "Allergy relief." These claims are not allowed on the product box as a dietary supplement. We need to present FDA sufficient evidence to FDA to prove AllerPops has those functions. This requires significant time, effort, and patience and will be another layer of protection for our brand. The links to the patents are: https://allerpops.com/wp-content/uploads/2019/09/US9795579B1.pdf https://allerpops.com/wp-content/uploads/2020/12/US10398670-patent-3.pdf https://allerpops.com/wp-content/uploads/2020/12/US10471033.pdf Thanks, Cliff